MedTrace Logo

Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI

NCT03266848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-08-24

No results posted yet for this study

Summary

This trial will evaluate a non-invasive brain imaging technique QUTE-CE MRI and validate the method with first-in-human studies.

Conditions

  • Cerebrovascular Disorders

Interventions

DIAGNOSTIC_TEST

Quantitative Magnetic Resonance Imaging

Radiological diagnosis

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Northeastern University

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Theranano LLC

    lead INDUSTRY

Principal Investigators

  • Srinivas Sridhar, Ph.D. · Theranano LLC

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-08
Primary Completion
2020-07-22
Completion
2020-07-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266848 on ClinicalTrials.gov